FI112600B - Tuetulla nestekalvolla varustettuja antovälineitä - Google Patents

Tuetulla nestekalvolla varustettuja antovälineitä Download PDF

Info

Publication number
FI112600B
FI112600B FI935299A FI935299A FI112600B FI 112600 B FI112600 B FI 112600B FI 935299 A FI935299 A FI 935299A FI 935299 A FI935299 A FI 935299A FI 112600 B FI112600 B FI 112600B
Authority
FI
Finland
Prior art keywords
hydrophobic
film
enzyme
hydrophobic liquid
membrane
Prior art date
Application number
FI935299A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI935299A0 (fi
FI935299A (fi
Inventor
Scott M Herbig
Kelly L Smith
Eikeren Paul Van
James B West
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI935299A0 publication Critical patent/FI935299A0/fi
Publication of FI935299A publication Critical patent/FI935299A/fi
Application granted granted Critical
Publication of FI112600B publication Critical patent/FI112600B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/009—Sachets, pouches characterised by the material or function of the envelope
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Laminated Bodies (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
FI935299A 1992-11-30 1993-11-29 Tuetulla nestekalvolla varustettuja antovälineitä FI112600B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98281592A 1992-11-30 1992-11-30
US98281592 1992-11-30

Publications (3)

Publication Number Publication Date
FI935299A0 FI935299A0 (fi) 1993-11-29
FI935299A FI935299A (fi) 1994-05-31
FI112600B true FI112600B (fi) 2003-12-31

Family

ID=25529534

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935299A FI112600B (fi) 1992-11-30 1993-11-29 Tuetulla nestekalvolla varustettuja antovälineitä

Country Status (10)

Country Link
US (1) US5603953A (ja)
EP (1) EP0670717B1 (ja)
JP (1) JP2847326B2 (ja)
AT (1) ATE173616T1 (ja)
CA (1) CA2150019C (ja)
DE (1) DE69322286T2 (ja)
DK (1) DK0670717T3 (ja)
ES (1) ES2123665T3 (ja)
FI (1) FI112600B (ja)
WO (1) WO1994012159A1 (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465188B1 (en) * 1990-06-11 2002-10-15 Gilead Sciences, Inc. Nucleic acid ligand complexes
US5985164A (en) * 1994-03-07 1999-11-16 Regents Of The University Of California Method for forming a filter
US5893974A (en) * 1994-03-07 1999-04-13 Regents Of University Of California Microfabricated capsules for immunological isolation of cell transplants
US5770076A (en) * 1994-03-07 1998-06-23 The Regents Of The University Of California Micromachined capsules having porous membranes and bulk supports
US5798042A (en) * 1994-03-07 1998-08-25 Regents Of The University Of California Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters
US5985328A (en) * 1994-03-07 1999-11-16 Regents Of The University Of California Micromachined porous membranes with bulk support
ES2163504T5 (es) 1994-05-06 2008-05-16 Pfizer Inc. Formas de dosificacion de liberacion controlada de azitromicina.
US8071737B2 (en) * 1995-05-04 2011-12-06 Glead Sciences, Inc. Nucleic acid ligand complexes
GB9509764D0 (en) * 1995-05-15 1995-07-05 Tillotts Pharma Ag Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
GB9609094D0 (en) * 1996-05-01 1996-07-03 Univ Strathclyde Delivery device
US6086769A (en) * 1996-09-16 2000-07-11 Commodore Separation Technologies, Inc. Supported liquid membrane separation
US5938923A (en) * 1997-04-15 1999-08-17 The Regents Of The University Of California Microfabricated filter and capsule using a substrate sandwich
US6248391B1 (en) * 1997-07-16 2001-06-19 Bpsi Holdings, Inc. Bright white film coatings and film coating compositions therefor
PT1051217E (pt) * 1997-12-31 2003-12-31 Alza Corp Sistema de controlo osmotico de administracao de medicamento
PL192270B1 (pl) * 1998-03-19 2006-09-29 Merck & Co Inc Ciekła kompozycja polimeryczna do kontrolowanego uwalniania eprinomektyny
FR2790404B1 (fr) * 1999-03-01 2001-11-02 Virbac Sa Compositions pour le domaine aquatique contenant au moins une molecule active contenue dans au moins un vecteur microparticulaire ou nanoparticulaire, et son utilisation
GB9920170D0 (en) * 1999-08-25 1999-10-27 Univ Portsmouth A passive sampling device
US6521188B1 (en) * 2000-11-22 2003-02-18 Industrial Technology Research Institute Microfluidic actuator
WO2002088672A1 (en) * 2001-04-26 2002-11-07 Varian, Inc. Hollow fiber membrane sample preparation devices
PT1575565E (pt) * 2003-08-08 2010-03-03 Biovail Lab Int Srl Comprimido de libertação modificada de cloridrato de bupropiona
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
US7445939B2 (en) * 2004-02-27 2008-11-04 Varian, Inc. Stable liquid membranes for liquid phase microextraction
US20070181054A1 (en) * 2006-02-03 2007-08-09 Adair Joel E Heated volatile dispensing device with use-up indicator
JP4327841B2 (ja) * 2006-12-20 2009-09-09 日東電工株式会社 経皮吸収製剤の製造装置および製造方法
US20090095164A1 (en) * 2007-05-17 2009-04-16 Salvatore Albert Celeste Method of enhancing beverages by means of a unique microencapsulated delivery system
US11039707B2 (en) * 2007-05-17 2021-06-22 International Flavors & Fragrances Inc. Microencapsulated delivery system
US10588857B2 (en) 2012-03-29 2020-03-17 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
BR112015023124A2 (pt) 2013-03-14 2017-07-18 Therabiome Llc liberação de organismos probióticos e/ou agentes terapêuticos almejada para o trato gastrintestinal
US11213791B2 (en) * 2015-10-23 2022-01-04 Hewlett-Packard Development Company, L.P. Nano wire microporous structure
WO2018200808A1 (en) 2017-04-26 2018-11-01 The Penn State Research Foundation Free-standing liquid membranes for substance separation, filtration, extraction, and blockage

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965255A (en) * 1974-05-01 1976-06-22 E. E. Eljim Ecology Ltd. Controlled drug releasing preparations
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
US4016880A (en) * 1976-03-04 1977-04-12 Alza Corporation Osmotically driven active agent dispenser
US4201691A (en) * 1978-01-16 1980-05-06 Exxon Research & Engineering Co. Liquid membrane generator
US4183960A (en) * 1978-02-01 1980-01-15 Exxon Research & Engineering Co. Detoxification by means of the controlled, in vivo secretion triggered rupture of liquid membrane capsules
EP0162492B1 (en) * 1984-04-11 1989-08-02 Thiemann Arzneimittel GmbH Dosage units for controlled release of active material
US4657543A (en) * 1984-07-23 1987-04-14 Massachusetts Institute Of Technology Ultrasonically modulated polymeric devices for delivering compositions
DE3485618D1 (de) * 1984-08-17 1992-04-30 Wellcome Found Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und ihre herstellung.
JPH0739457B2 (ja) * 1986-05-14 1995-05-01 タキロン株式会社 両親媒性セグメントポリウレタン
FR2599270B3 (fr) * 1986-06-03 1988-12-30 Pharmacie Galenique Lab Procede de preparation d'une membrane destinee a tester la diffusion passive des medicaments.
US5034317A (en) * 1987-01-30 1991-07-23 Polaroid Corporation Enzyme controlled release system and organic conjugate reactant
US5057320A (en) * 1988-08-01 1991-10-15 Nutrition 21 Means and method for increasing skin respiration
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US5026342A (en) * 1988-10-26 1991-06-25 Biopore, Inc. Noningestible separation barrier with plugged pores
JPH0794379B2 (ja) * 1990-08-07 1995-10-11 ファイザー・インコーポレーテッド 放出製剤における界面重合膜の使用方法
DK0550641T3 (da) * 1990-09-28 1994-08-22 Pfizer Dispenseringsanordning indeholdende et hydrofobt medium
DE9015551U1 (ja) * 1990-11-14 1992-03-12 Roehm Gmbh, 6100 Darmstadt, De

Also Published As

Publication number Publication date
FI935299A0 (fi) 1993-11-29
EP0670717B1 (en) 1998-11-25
CA2150019C (en) 1999-01-05
DE69322286D1 (de) 1999-01-07
JP2847326B2 (ja) 1999-01-20
US5603953A (en) 1997-02-18
DK0670717T3 (da) 1999-08-09
ATE173616T1 (de) 1998-12-15
EP0670717A1 (en) 1995-09-13
FI935299A (fi) 1994-05-31
DE69322286T2 (de) 1999-04-22
JPH07509254A (ja) 1995-10-12
ES2123665T3 (es) 1999-01-16
CA2150019A1 (en) 1994-06-09
WO1994012159A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
FI112600B (fi) Tuetulla nestekalvolla varustettuja antovälineitä
US10314787B2 (en) Controlled release delivery device comprising an organosol coat
US5827538A (en) Osmotic devices having vapor-permeable coatings
RU2130311C1 (ru) Лекарственные формы азитромицина с контролируемым высвобождением
CA2177972C (en) Device for effecting the controlled release of active substances
CA2089738C (en) Dispensing device containing a hydrophobic medium
FI108610B (fi) Rajapintapolymeroitujen membraanien käyttö annosteluvälineissä
FR2580499A1 (fr) Dispositif osmotique d'apport ayant un passage automatiquement ferme
CA2148837C (en) Delivery device having encapsulated excipients
FR2554001A1 (fr) Capsule osmotique pour l'apport de substances actives a un milieu environnant
FR2604904A1 (fr) Dispositif d'apport de substances a un milieu environnant
IE62859B1 (en) The use of asymmetric membranes in delivery devices
ZA200500834B (en) Oral dosage form comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
FR2561628A1 (fr) Dispositif d'apport de substances a plusieurs elements fonctionnant en systeme unitaire integre
US4960416A (en) Dosage form with improved delivery capability
US20090110727A1 (en) Extended release compositions of proton pump inhibitors
FR2598079A1 (fr) Forme de dosage pour un meilleur apport de substances a un milieu
WO2004103291A2 (en) Extended release compositions of proton pump inhibitor

Legal Events

Date Code Title Description
MA Patent expired